22:39:41 EDT Mon 15 Jul 2024
Enter Symbol
or Name
USA
CA



Login ID:
Password:
Save

News for U:OTLK from 2023-07-16 to 2024-07-15 - 99 items News ReleasesIn The NewsOther CAUS
DateSymPriceTypeHeadline
2024-07-08 08:35U:OTLKNews ReleaseOutlook Therapeutics(TM) Announces UK MHRA Marketing Authorization of LYTENAVA(TM) (bevacizumab gamma) for the Treatment of Wet AMD
2024-06-11 09:05U:OTLKNews ReleaseOutlook Therapeutics(TM) to Present at the Virtual Investor Pitch Conference
2024-05-28 08:05U:OTLKNews ReleaseOutlook Therapeutics(TM) Receives European Commission Marketing Authorization for LYTENAVA(TM) (bevacizumab gamma) for the Treatment of Wet AMD
2024-05-15 17:00U:OTLKNews ReleaseOutlook Therapeutics(TM) Reports Financial Results for Second Quarter Fiscal Year 2024 and Provides Corporate Update
2024-05-13 08:50U:OTLKNews ReleaseOutlook Therapeutics(TM) Announces UK Submission of Marketing Authorization Application (MAA) for ONS-5010 as a Treatment for Wet AMD
2024-05-09 08:45U:OTLKNews ReleaseOutlook Therapeutics(TM) to Report Financial Results for Second Quarter Fiscal Year 2024 on May 16, 2024 and Host Inaugural Quarterly Conference Call and Webcast
2024-05-02 09:05U:OTLKNews ReleaseOutlook Therapeutics(TM) to Present at the Retina World Congress 2024
2024-04-29 09:00U:OTLKNews ReleaseOutlook Therapeutics(TM) to Present at the Ophthalmology Innovation Summit (OIS) Retina Innovation Showcase
2024-04-15 16:15U:OTLKNews ReleaseOutlook Therapeutics(TM) Announces Closing of Private Placement of $5.0 Million
2024-03-22 07:36U:OTLKNews ReleaseOutlook Therapeutics(TM) Receives European Union Positive CHMP Opinion for ONS-5010 as a Treatment for Wet AMD
2024-03-18 17:10U:OTLKNews ReleaseOutlook Therapeutics(TM) Announces Closing of Private Placement of up to $159 Million
2024-03-12 08:05U:OTLKNews ReleaseOutlook Therapeutics(TM) Announces Effective Date for 1-for-20 Reverse Stock Split
2024-02-14 08:05U:OTLKNews ReleaseOutlook Therapeutics ‚ ® Reports Financial Results for First Quarter Fiscal Year 2024 and Provides Corporate Update
2024-01-31 08:05U:OTLKNews ReleaseOutlook Therapeutics ‚ ® Doses First Subject in NORSE EIGHT
2024-01-23 08:00U:OTLKNews ReleaseOutlook Therapeutics ‚ ® Receives FDA Agreement Under Special Protocol Assessment (SPA) for 90 Day Non-Inferiority Study, NORSE EIGHT, and Announces Private Placement of Up to $172 Million to Advance ONS-5010
2024-01-01 17:04U:OTLKNews ReleaseOTLK DEADLINE TOMORROW: ROSEN, A LEADING LAW FIRM, Encourages Outlook Therapeutics, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action - OTLK
2023-12-31 12:04U:OTLKNews ReleaseOTLK IMPORTANT DEADLINE: ROSEN, SKILLED INVESTOR COUNSEL, Encourages Outlook Therapeutics, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action - OTLK
2023-12-30 09:08U:OTLKNews ReleaseOTLK DEADLINE ALERT: ROSEN, A LEADING AND RANKED FIRM, Encourages Outlook Therapeutics, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action - OTLK
2023-12-29 20:35U:OTLKNews ReleaseOTLK DEADLINE ALERT: ROSEN, NATIONAL INVESTOR COUNSEL, Encourages Outlook Therapeutics, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action - OTLK
2023-12-28 16:03U:OTLKNews ReleaseOTLK DEADLINE ALERT: ROSEN, RECOGNIZED INVESTOR COUNSEL, Encourages Outlook Therapeutics, Inc. Investors to Secure Counsel Before Important January 2 Deadline in Securities Class Action - OTLK
2023-12-25 14:34U:OTLKNews ReleaseROSEN, A LEADING AND LONGSTANDING FIRM, Encourages Outlook Therapeutics, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action - OTLK
2023-12-23 17:37U:OTLKNews ReleaseROSEN, A LEADING INVESTOR RIGHTS LAW FIRM, Encourages Outlook Therapeutics, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action - OTLK
2023-12-22 08:05U:OTLKNews ReleaseOutlook Therapeutics ‚ ® Reports Financial Results for Fiscal Year 2023 and Reiterates ONS-5010 Clinical and Regulatory Path Forward in the U.S. and EU
2023-12-21 03:32U:OTLKNews ReleaseTOP RANKED ROSEN LAW FIRM Encourages Outlook Therapeutics, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action - OTLK
2023-12-19 08:05U:OTLKNews ReleaseOutlook Therapeutics ‚ ® Submits Special Protocol Assessment (SPA) to FDA for Non-Inferiority Study of ONS-5010
2023-12-19 01:00U:OTLKNews ReleaseROSEN, A LEADING NATIONAL FIRM, Encourages Outlook Therapeutics, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action - OTLK
2023-12-16 05:30U:OTLKNews ReleaseROSEN, TRUSTED INVESTOR COUNSEL, Encourages Outlook Therapeutics, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action - OTLK
2023-12-11 11:46U:OTLKNews ReleaseINVESTOR ALERT: Levi & ‚  Korsinsky Notifies Shareholders of Outlook Therapeutics, Inc.(OTLK) of a Class Action Lawsuit and an Upcoming Deadline
2023-12-11 06:17U:OTLKNews ReleaseINVESTOR ALERT: Levi & ‚  Korsinsky Notifies Shareholders of Outlook Therapeutics, Inc.(OTLK) of a Class Action Lawsuit and an Upcoming Deadline
2023-12-11 05:35U:OTLKNews ReleaseIMPORTANT DEADLINE REMINDER: The Schall Law Firm Encourages Investors in Outlook Therapeutics, Inc. with Losses of $500,000 to Contact the Firm
2023-12-10 15:31U:OTLKNews ReleaseSHAREHOLDER ALERT: Levi & ‚  Korsinsky Reminds Outlook Therapeutics, Inc. Investors of the Pending Class Action Lawsuit with a Lead Plaintiff Deadline of ‚  January 2, 2024 - ‚  OTLK
2023-12-10 15:01U:OTLKNews ReleaseOTLK Class Action Alert: Bronstein, Gewirtz & Grossman LLC Reminds Outlook Therapeutics, Inc. Investors with Substantial Losses to Contact the Firm!
2023-12-10 08:46U:OTLKNews ReleaseINVESTOR ALERT: Levi & ‚  Korsinsky Reminds Shareholders of a Lead Plaintiff Deadline of ‚  January 2, 2024 in ‚  Outlook Lawsuit - ‚  OTLK
2023-12-09 19:02U:OTLKNews ReleaseINVESTOR ALERT: Contact Levi & ‚  Korsinsky Before ‚  January 2, 2024 to Discuss Your Rights - ‚  OTLK
2023-12-09 18:30U:OTLKNews ReleaseROSEN, SKILLED INVESTOR COUNSEL, Encourages Outlook Therapeutics, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action - OTLK
2023-12-08 13:11U:OTLKNews ReleaseSHAREHOLDER ALERT: Levi & ‚  Korsinsky Reminds Outlook Therapeutics, Inc. Investors of the Pending Class Action Lawsuit with a Lead Plaintiff Deadline of ‚  January 2, 2024 - ‚  OTLK
2023-12-08 11:47U:OTLKNews ReleaseSHAREHOLDER ALERT: Contact Levi & ‚  Korsinsky Before ‚  January 2, 2024 to Discuss Your Rights - ‚  OTLK
2023-12-08 11:25U:OTLKNews ReleaseSHAREHOLDER ALERT: Pomerantz Law Firm Reminds Shareholders with Losses on their Investment in Outlook Therapeutics, Inc. of Class Action Lawsuit and Upcoming Deadline - OTLK
2023-12-08 07:46U:OTLKNews ReleaseSHAREHOLDER ALERT: Levi & ‚  Korsinsky Reminds Shareholders of a Lead Plaintiff Deadline of ‚  January 2, 2024 in ‚  Outlook Lawsuit - ‚  OTLK
2023-12-08 07:17U:OTLKNews ReleaseOTLK Shareholder Alert: Bronstein, Gewirtz & Grossman LLC Reminds Outlook Therapeutics, Inc. Investors with Substantial Losses to Contact the Firm!
2023-12-08 00:00U:OTLKNews ReleaseROSEN, A RANKED AND LEADING FIRM, Encourages Outlook Therapeutics, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action - OTLK
2023-12-07 18:07U:OTLKNews ReleaseINVESTOR ALERT: Contact Levi & ‚  Korsinsky Before ‚  January 2, 2024 to Discuss Your Rights ¢ € “ ‚  OTLK
2023-12-07 13:01U:OTLKNews ReleaseSHAREHOLDER ALERT: Levi & ‚  Korsinsky Reminds Shareholders of a Lead Plaintiff Deadline of ‚  January 2, 2024 in ‚  Outlook Lawsuit - ‚  OTLK
2023-12-07 12:16U:OTLKNews ReleaseSHAREHOLDER ALERT: Levi & ‚  Korsinsky Reminds Shareholders of a Lead Plaintiff Deadline of ‚  January 2, 2024 in ‚  Outlook Lawsuit - ‚  OTLK
2023-12-07 11:31U:OTLKNews ReleaseSHAREHOLDER ALERT: Levi & ‚  Korsinsky Notifies Outlook Therapeutics, Inc. Investors of a Class Action Lawsuit and Upcoming Deadline - ‚  OTLK
2023-12-07 09:31U:OTLKNews ReleaseINVESTOR ALERT: Contact Levi & ‚  Korsinsky Before ‚  January 2, 2024 to Discuss Your Rights - ‚  OTLK
2023-12-07 07:31U:OTLKNews ReleaseINVESTOR ALERT: Levi & ‚  Korsinsky Reminds Outlook Therapeutics, Inc. Investors of the Pending Class Action Lawsuit with a Lead Plaintiff Deadline of ‚  January 2, 2024 - ‚  OTLK
2023-12-07 07:17U:OTLKNews ReleaseOTLK Shareholder Alert: Bronstein, Gewirtz & Grossman LLC Reminds Outlook Therapeutics, Inc. Investors with Substantial Losses to Contact the Firm!
2023-12-06 21:16U:OTLKNews ReleaseSHAREHOLDER ALERT: Levi & ‚  Korsinsky Notifies Outlook Therapeutics, Inc. Investors of a Class Action Lawsuit and Upcoming Deadline ¢ € “ ‚  OTLK
2023-12-06 12:32U:OTLKNews ReleaseSHAREHOLDER ALERT: Levi & ‚  Korsinsky Notifies Shareholders of Outlook Therapeutics, Inc.(OTLK) of a Class Action Lawsuit and an Upcoming Deadline
2023-12-06 11:38U:OTLKNews ReleaseSHAREHOLDER ALERT: Levi & ‚  Korsinsky Notifies Shareholders of Outlook Therapeutics, Inc.(OTLK) of a Class Action Lawsuit and an Upcoming Deadline
2023-12-06 08:05U:OTLKNews ReleaseOutlook Therapeutics ‚ ® Announces Strategic Organizational Realignment
2023-12-06 07:32U:OTLKNews ReleaseINVESTOR ALERT: Contact Levi & ‚  Korsinsky Before ‚  January 2, 2024 to Discuss Your Rights - ‚  OTLK
2023-12-05 21:00U:OTLKNews ReleaseROSEN, TRUSTED INVESTOR COUNSEL, Encourages Outlook Therapeutics, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action - OTLK
2023-12-05 12:17U:OTLKNews ReleaseSHAREHOLDER ALERT: Contact Levi & ‚  Korsinsky Before ‚  January 2, 2024 to Discuss Your Rights - ‚  OTLK
2023-12-05 10:19U:OTLKNews ReleaseSHAREHOLDER ALERT: Levi & ‚  Korsinsky Reminds Outlook Therapeutics, Inc. Investors of the Pending Class Action Lawsuit with a Lead Plaintiff Deadline of ‚  January 2, 2024 - ‚  OTLK
2023-12-05 07:31U:OTLKNews ReleaseINVESTOR ALERT: Levi & ‚  Korsinsky Notifies Shareholders of Outlook Therapeutics, Inc.(OTLK) of a Class Action Lawsuit and an Upcoming Deadline
2023-12-05 07:19U:OTLKNews ReleaseOTLK Shareholder Alert: Bronstein, Gewirtz & Grossman LLC Reminds Outlook Therapeutics, Inc. Investors with Substantial Losses to Contact the Firm!
2023-12-05 02:20U:OTLKNews ReleaseINVESTOR ALERT: Levi & ‚  Korsinsky Notifies Outlook Therapeutics, Inc. Investors of a Class Action Lawsuit and Upcoming Deadline - ‚  OTLK
2023-12-04 18:17U:OTLKNews ReleaseSHAREHOLDER ALERT: Potential Recovery for Outlook Therapeutics, Inc. (OTLK) Investors Affected by Stock Drop - Levi & Korsinsky Pursuing Class Action Lawsuit
2023-12-04 16:17U:OTLKNews ReleaseINVESTOR ALERT: Contact Levi & ‚  Korsinsky Before ‚  January 2, 2024 to Discuss Your Rights - ‚  OTLK
2023-12-04 12:19U:OTLKNews ReleaseINVESTOR ALERT: Potential Recovery for Outlook Therapeutics, Inc. (OTLK) Investors Affected by Stock Drop - Levi & Korsinsky Pursuing Class Action Lawsuit
2023-12-04 08:29U:OTLKNews ReleaseIMPORTANT DEADLINE REMINDER: The Schall Law Firm Reminds Investors in Outlook Therapeutics, Inc. with Losses In Excess of $500,000 to Contact the Firm
2023-12-04 07:22U:OTLKNews ReleaseINVESTOR ALERT: Potential Recovery for Outlook Therapeutics, Inc. (OTLK) Investors Affected by Stock Drop - Levi & Korsinsky Pursuing Class Action Lawsuit
2023-12-03 17:21U:OTLKNews ReleaseSHAREHOLDER ALERT: Contact Levi & ‚  Korsinsky Before ‚  January 2, 2024 to Discuss Your Rights - ‚  OTLK
2023-12-03 09:02U:OTLKNews ReleaseSHAREHOLDER ALERT: Levi & ‚  Korsinsky Notifies Shareholders of Outlook Therapeutics, Inc.(OTLK) of a Class Action Lawsuit and an Upcoming Deadline
2023-12-03 07:31U:OTLKNews ReleaseINVESTOR ALERT: Levi & ‚  Korsinsky Reminds Shareholders of a Lead Plaintiff Deadline of ‚  January 2, 2024 in ‚  Outlook Lawsuit - ‚  OTLK
2023-12-03 07:21U:OTLKNews ReleaseOTLK Shareholder Alert: Bronstein, Gewirtz & Grossman LLC Reminds Outlook Therapeutics, Inc. Investors with Substantial Losses to Contact the Firm!
2023-12-03 06:42U:OTLKNews ReleaseSHAREHOLDER ACTION ALERT: The Schall Law Firm Encourages Investors in Outlook Therapeutics, Inc. with Losses In Excess of $100,000 to Contact the Firm
2023-12-02 19:02U:OTLKNews ReleaseINVESTOR ALERT: Levi & ‚  Korsinsky Notifies Shareholders of Outlook Therapeutics, Inc.(OTLK) of a Class Action Lawsuit and an Upcoming Deadline
2023-12-02 10:40U:OTLKNews ReleaseSHAREHOLDER ALERT: Pomerantz Law Firm Reminds Shareholders with Losses on their Investment in Outlook Therapeutics, Inc. of Class Action Lawsuit and Upcoming Deadline - OTLK
2023-12-01 18:02U:OTLKNews ReleaseINVESTOR ALERT: Levi & ‚  Korsinsky Notifies Outlook Therapeutics, Inc. Investors of a Class Action Lawsuit and Upcoming Deadline ¢ € “ ‚  OTLK
2023-12-01 16:33U:OTLKNews ReleaseINVESTOR ALERT: Levi & ‚  Korsinsky Reminds Shareholders of a Lead Plaintiff Deadline of ‚  January 2, 2024 in ‚  Outlook Lawsuit - ‚  OTLK
2023-12-01 12:46U:OTLKNews ReleaseINVESTOR ALERT: Potential Recovery for Outlook Therapeutics, Inc. (OTLK) Investors Affected by Stock Drop - Levi & Korsinsky Pursuing Class Action Lawsuit
2023-12-01 07:31U:OTLKNews ReleaseINVESTOR ALERT: Levi & ‚  Korsinsky Reminds Shareholders of a Lead Plaintiff Deadline of ‚  January 2, 2024 in ‚  Outlook Lawsuit - ‚  OTLK
2023-12-01 07:17U:OTLKNews ReleaseOTLK Shareholder Alert: Bronstein, Gewirtz & Grossman LLC Reminds Outlook Therapeutics, Inc. Investors with Substantial Losses to Contact the Firm!
2023-12-01 06:26U:OTLKNews ReleaseINVESTOR ALERT: Potential Recovery for Outlook Therapeutics, Inc. (OTLK) Investors Affected by Stock Drop - Levi & Korsinsky Pursuing Class Action Lawsuit
2023-12-01 06:05U:OTLKNews ReleaseFINAL DEADLINE APPROACHING: The Schall Law Firm Encourages Investors in Outlook Therapeutics, Inc. with Losses of $100,000 to Contact the Firm
2023-11-30 23:00U:OTLKNews ReleaseROSEN, A LEADING INVESTOR RIGHTS LAW FIRM Encourages Outlook Therapeutics, Inc. Investors with Losses to Secure Counsel Before Important Deadline in Securities Class Action - OTLK
2023-11-30 16:32U:OTLKNews ReleaseSHAREHOLDER ALERT: Potential Recovery for Outlook Therapeutics, Inc. (OTLK) Investors Affected by Stock Drop - Levi & Korsinsky Pursuing Class Action Lawsuit
2023-11-30 12:47U:OTLKNews ReleaseSHAREHOLDER ALERT: Levi & ‚  Korsinsky Notifies Outlook Therapeutics, Inc. Investors of a Class Action Lawsuit and Upcoming Deadline - ‚  OTLK
2023-11-30 12:29U:OTLKNews ReleaseSHAREHOLDER ALERT: Levi & ‚  Korsinsky Notifies Outlook Therapeutics, Inc. Investors of a Class Action Lawsuit and Upcoming Deadline - ‚  OTLK
2023-11-30 11:32U:OTLKNews ReleaseSHAREHOLDER ALERT: Contact Levi & ‚  Korsinsky Before ‚  January 2, 2024 to Discuss Your Rights - ‚  OTLK
2023-11-28 01:00U:OTLKNews ReleaseROSEN, A RESPECTED AND LEADING FIRM, Encourages Outlook Therapeutics, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action - OTLK
2023-11-27 08:05U:OTLKNews ReleaseOutlook Therapeutics ‚ ® Announces Receipt of Type A Meeting Minutes and Reiterates Regulatory Path Forward for ONS-5010
2023-11-23 19:31U:OTLKNews ReleaseNATIONALLY RANKED ROSEN LAW FIRM Encourages Outlook Therapeutics, Inc. Investors with Losses to Secure Counsel Before Important Deadline in Securities Class Action - OTLK
2023-11-21 22:00U:OTLKNews ReleaseROSEN, RECOGNIZED INVESTOR COUNSEL, Encourages Outlook Therapeutics, Inc. Investors with Losses to Secure Counsel Before Important Deadline in Securities Class Action - OTLK
2023-11-16 02:30U:OTLKNews ReleaseROSEN, LEADING INVESTOR COUNSEL, Encourages Outlook Therapeutics, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action - OTLK
2023-11-14 08:05U:OTLKNews ReleaseOutlook Therapeutics ‚ ® Adds Global Commercial Expertise with Appointment of Jedd Comiskey as Senior VP - Head of Europe
2023-11-12 01:01U:OTLKNews ReleaseROSEN, GLOBAL INVESTOR COUNSEL, Encourages Outlook Therapeutics, Inc. Investors with Losses to Secure Counsel Before Important Deadline in Securities Class Action - OTLK
2023-11-10 03:41U:OTLKNews ReleaseROSEN, RECOGNIZED INVESTOR COUNSEL, Encourages Outlook Therapeutics, Inc. Investors with Losses to Secure Counsel Before Important Deadline in Securities Class Action - OTLK
2023-11-02 08:05U:OTLKNews ReleaseOutlook Therapeutics ‚ ® Provides Update on Type A Meetings with FDA
2023-11-01 08:05U:OTLKNews ReleaseOutlook Therapeutics ‚ ® to Present at Guggenheim ¢ € ™s 5th Annual Inflammation, Neurology & Immunology (INI) Conference
2023-09-29 08:05U:OTLKNews ReleaseOutlook Therapeutics ‚ ® Requests Type A Meeting With FDA
2023-09-21 08:05U:OTLKNews ReleaseOutlook Therapeutics ‚ ® to Present at the 2023 Cantor Fitzgerald Global Healthcare Conference
2023-09-05 08:05U:OTLKNews ReleaseOutlook Therapeutics ‚ ® to Present at the H.C. Wainwright 25th Annual Global Investment Conference
2023-08-30 06:00U:OTLKNews ReleaseOutlook Therapeutics ‚ ® Provides Regulatory Update on FDA Review of ONS-5010 / LYTENAVA ¢ „ ¢ (bevacizumab-vikg) for the Treatment of Wet AMD
2023-08-14 08:05U:OTLKNews ReleaseOutlook Therapeutics ‚ ® Reports Financial Results for Third Quarter Fiscal Year 2023 and Reiterates Key Anticipated Near-Term Milestones
2023-08-01 08:45U:OTLKNews ReleaseOutlook Therapeutics ‚ ® to Present at the BTIG Virtual Biotechnology Conference 2023